Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimated Long-Term Survival With Eplerenone.
Stienen S, Ferreira JP, Vincent J, Busselen M, Li B, McMurray JJV, Pitt B, Girerd N, Rossignol P, Zannad F. Stienen S, et al. Among authors: pitt b. J Am Coll Cardiol. 2019 May 14;73(18):2357-2359. doi: 10.1016/j.jacc.2019.02.043. J Am Coll Cardiol. 2019. PMID: 31072582 Free article. No abstract available.
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.
Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B; EMPHASIS-HF Study Investigators. Swedberg K, et al. Among authors: pitt b. J Am Coll Cardiol. 2012 May 1;59(18):1598-603. doi: 10.1016/j.jacc.2011.11.063. J Am Coll Cardiol. 2012. PMID: 22538330 Free article. Clinical Trial.
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF Investigators. Eschalier R, et al. Among authors: pitt b. J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93. doi: 10.1016/j.jacc.2013.04.086. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810881 Free article. Clinical Trial.
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, van Veldhuisen DJ, Zannad F, Krum H, Mukherjee R, Vincent J; EPHESUS Investigators. Pitt B, et al. J Am Coll Cardiol. 2005 Aug 2;46(3):425-31. doi: 10.1016/j.jacc.2005.04.038. J Am Coll Cardiol. 2005. PMID: 16053953 Free article. Clinical Trial.
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F. Rossignol P, et al. Among authors: pitt b. J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66. doi: 10.1016/j.jacc.2011.04.049. J Am Coll Cardiol. 2011. PMID: 22032706 Free article.
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
Ferreira JP, Girerd N, Gregson J, Latar I, Sharma A, Pfeffer MA, McMurray JJV, Abdul-Rahim AH, Pitt B, Dickstein K, Rossignol P, Zannad F; High-Risk Myocardial Infarction Database Initiative. Ferreira JP, et al. Among authors: pitt b. J Am Coll Cardiol. 2018 Feb 20;71(7):727-735. doi: 10.1016/j.jacc.2017.12.011. J Am Coll Cardiol. 2018. PMID: 29447733 Free article. Clinical Trial.
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).
Frikha Z, Ferreira JP, Bozec E, McMurray JJV, Pitt B, Dickstein K, Rossignol P, Zannad F, Girerd N; High-Risk Myocardial Infarction Database Initiative Investigators. Frikha Z, et al. Among authors: pitt b. Am J Cardiol. 2018 May 1;121(9):1015-1020. doi: 10.1016/j.amjcard.2018.01.012. Epub 2018 Feb 5. Am J Cardiol. 2018. PMID: 29631805
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.
Ferreira JP, Barros A, Pitt B, Montalescot G, de Sa EL, Hamm CW, Flather M, Verheugt F, Shi H, Leite-Moreira A, Vincent J, Rossignol P, Zannad F. Ferreira JP, et al. Among authors: pitt b. Clin Res Cardiol. 2018 Dec;107(12):1192-1195. doi: 10.1007/s00392-018-1373-5. Epub 2018 Sep 27. Clin Res Cardiol. 2018. PMID: 30264283 No abstract available.
1,206 results